참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Formaldehyde | HCID 712 | — |
| 반응물 | 1,3,5-Trimethyl-1,3,5-triazacyclohexane | HCID 7952 | — |
| 반응물 | 1-Amino-4-methylpiperazine | HCID 81349 | — |
| 반응물 | Rifamycin | HCID 6324616 | — |
| 반응물 | Rifamycin S | HCID 6436726 | — |
| 용매 | Acetic Acid | HCID 176 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | Rifampicin | HCID 135398735 | — |
반응 단계
7 g. Rifamycin S are dissolved in 25 ml. dimethylformamide, then, while stirring, there are successively added 2.4 g. acetic acid, 0.6 g. paraformaldehyde and 0.85 g. 1,3,5-trimethyl-hexahydro-1,3,5-triazine. The mixture is then kept at 50° C. for 3 hours until the reaction is completed, with the formation of 3-methyl-1,3-oxazino (5,6-c) rifamycin (thin layer chromatography on silica gel 60 F254 - Merck: blue spot at Rf 0.19, eluent chloroform:methanol 9:1 v/v). 3.1 g. 1-amino-4-methylpiperazine are then added and the reaction is continued at 50° C. for about 1 hour until it is completed, as demonstrated by the disappearance of the blue spot in the TLC. After treatment in the usual way, a high yield (7.2 g.) of rifampicin is obtained. It can easily be purified by crystallisation from acetone.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04174320 |
|---|
| 출처 데이터셋 | uspto-grants-1979_11 |
|---|
| ORD ID | ord-720ad38bec7f46d0aac4239ff9d6ccb0 |
|---|
| 출처 메모 | uspto-grants-1979_11 |
|---|